The burden of neovascular age-related macular degeneration: a patient’s perspective
Open Access
- 1 December 2018
- journal article
- research article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. ume 12, 2483-2491
Abstract
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articles or submit your research for publishing.Keywords
This publication has 33 references indexed in Scilit:
- Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration2012
- Adherence to ranibizumab treatment for neovascular age-related macular degeneration in real lifeGraefe's Archive for Clinical and Experimental Ophthalmology, 2012
- The Impact of Visual and Nonvisual Factors on Quality of Life and Adaptation in Adults with Visual ImpairmentInvestigative Ophthalmology & Visual Science, 2012
- Comparison of Scoring Approaches for the NEI VFQ‐25 in Low VisionOptometry and Vision Science, 2010
- Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational studyQuality of Life Research, 2010
- Current and emerging therapies for the treatment of age-related macular degenerationClinical Ophthalmology, 2008
- Association between Visual Acuity and Medical and Non-Medical Costs in Patients with Wet Age-Related Macular Degeneration in France, Germany and ItalyDrugs & Aging, 2008
- Quality of Life in Patients With Age-related Macular Degeneration: Impact of the Condition and Benefits of TreatmentSurvey of Ophthalmology, 2005
- Colour vision testing as an aid to diagnosis and management of age related maculopathyBritish Journal of Ophthalmology, 2004
- Age-Related Macular Degeneration and Blindness due to Neovascular MaculopathyArchives of Ophthalmology (1950), 1984